Biblio

Export 957 results:
Author Title [ Type(Desc)] Year
Filters: First Letter Of Last Name is F  [Clear All Filters]
Journal Article
A. Alexander Raha, Henderson, J. W., Stott, S. R. W., Vuono, R., Foscarin, S., Friedland, R. P., Zaman, S. H., and Raha-Chowdhury, R., Neuroprotective Effect of TREM-2 in Aging and Alzheimer's Disease Model., J Alzheimers Dis, vol. 55, no. 1, pp. 199-217, 2017.
Y. Du, Fu, M., Wang, Y. Tian, and Dong, Z., Neuroprotective Effects of Ginsenoside Rf on Amyloid-β-Induced Neurotoxicity in vitro and in vivo., J Alzheimers Dis, vol. 64, no. 1, pp. 309-322, 2018.
C. Castillo, Bravo-Arrepol, G., Wendt, A., Saez-Orellana, F., Millar, C., Burgos, C. F., Gavilán, J., Pacheco, C., Ahumada-Rudolph, R., Napiórkowska, M., Pérez, C., Becerra, J., Fuentealba, J., and Cabrera-Pardo, J. R., Neuroprotective Properties of Eudesmin on a Cellular Model of Amyloid-β Peptide Toxicity., J Alzheimers Dis, vol. 94, no. s1, pp. S97-S108, 2023.
T. Ming Liew, Yu, J., Mahendran, R., Ng, T. - P., Kua, E. - H., and Feng, L., Neuropsychiatric and Cognitive Subtypes among Community-Dwelling Older Persons and the Association with DSM-5 Mild Neurocognitive Disorder: Latent Class Analysis., J Alzheimers Dis, vol. 62, no. 2, pp. 675-686, 2018.
G. M. Babulal, Stout, S. H., Head, D., Holtzman, D. M., Fagan, A. M., Morris, J. C., and Roe, C. M., Neuropsychiatric Symptoms and Alzheimer's Disease Biomarkers Predict Driving Decline: Brief Report., J Alzheimers Dis, vol. 58, no. 3, pp. 675-680, 2017.
R. Resende, Ferreira-Marques, M., Moreira, P., Coimbra, J. R. M., Baptista, S. J., Isidoro, C., Salvador, J. A. R., Dinis, T. C. P., Pereira, C. F., and Santos, A. E., New BACE1 Chimeric Peptide Inhibitors Selectively Prevent AβPPβ Cleavage Decreasing Amyloid-β Production and Accumulation in Alzheimer's Disease Models., J Alzheimers Dis, vol. 76, no. 4, pp. 1317-1337, 2020.
L. Guzmán-Martínez, Calfío, C., Farías, G. A., Vilches, C., Prieto, R., and Maccioni, R. B., New Frontiers in the Prevention, Diagnosis, and Treatment of Alzheimer's Disease., J Alzheimers Dis, vol. 82, no. s1, pp. S51-S63, 2021.
M. D. Fraser, Davies, J. R. T., and Chang, X., New Gold in Them Thar Hills: Testing a Novel Supply Route for Plant-Derived Galanthamine., J Alzheimers Dis, vol. 55, no. 4, pp. 1321-1325, 2017.
F. Sorrentino, Arighi, A., Serpente, M., Arosio, B., Arcaro, M., Visconte, C., Rotondo, E., Vimercati, R., Ferri, E., Fumagalli, G. G., Pietroboni, A. M., Carandini, T., Scarpini, E., Fenoglio, C., and Galimberti, D., Niemann-Pick Type C 1 (NPC1) and NPC2 Gene Variability in Demented Patients with Evidence of Brain Amyloid Deposition., J Alzheimers Dis, vol. 83, no. 3, pp. 1313-1323, 2021.
F. Sorrentino, Arighi, A., Serpente, M., Arosio, B., Arcaro, M., Visconte, C., Rotondo, E., Vimercati, R., Ferri, E., Fumagalli, G. G., Pietroboni, A. M., Carandini, T., Scarpini, E., Fenoglio, C., and Galimberti, D., Niemann-Pick Type C 1 (NPC1) and NPC2 Gene Variability in Demented Patients with Evidence of Brain Amyloid Deposition., J Alzheimers Dis, vol. 83, no. 3, pp. 1313-1323, 2021.
F. Sorrentino, Arighi, A., Serpente, M., Arosio, B., Arcaro, M., Visconte, C., Rotondo, E., Vimercati, R., Ferri, E., Fumagalli, G. G., Pietroboni, A. M., Carandini, T., Scarpini, E., Fenoglio, C., and Galimberti, D., Niemann-Pick Type C 1 (NPC1) and NPC2 Gene Variability in Demented Patients with Evidence of Brain Amyloid Deposition., J Alzheimers Dis, vol. 83, no. 3, pp. 1313-1323, 2021.
L. Feng, Langsetmo, L., Yaffe, K., Sun, Y., Fink, H. A., Shikany, J. M., Leung, P. C., Lane, N. E., and Cauley, J. A., No Effects of Black Tea on Cognitive Decline Among Older US Men: A Prospective Cohort Study., J Alzheimers Dis, vol. 65, no. 1, pp. 99-105, 2018.
L. Feng, Langsetmo, L., Yaffe, K., Sun, Y., Fink, H. A., Shikany, J. M., Leung, P. C., Lane, N. E., and Cauley, J. A., No Effects of Black Tea on Cognitive Decline Among Older US Men: A Prospective Cohort Study., J Alzheimers Dis, vol. 65, no. 1, pp. 99-105, 2018.
M. K. Lupton, Benyamin, B., Proitsi, P., Nyholt, D. R., Ferreira, M. A., Montgomery, G. W., Heath, A. C., Madden, P. A., Medland, S. E., Gordon, S. D., Lovestone, S., Tsolaki, M., Kloszewska, I., Soininen, H., Mecocci, P., Vellas, B., Powell, J. F., Bush, A. I., Wright, M. J., Martin, N. G., and Whitfield, J. B., No Genetic Overlap Between Circulating Iron Levels and Alzheimer's Disease., J Alzheimers Dis, vol. 59, no. 1, pp. 85-99, 2017.
S. M. G. Cioffi, Galimberti, D., Barocco, F., Spallazzi, M., Fenoglio, C., Serpente, M., Arcaro, M., Gardini, S., Scarpini, E., and Caffarra, P., Non Fluent Variant of Primary Progressive Aphasia Due to the Novel GRN g.9543delA(IVS3-2delA) Mutation., J Alzheimers Dis, vol. 54, no. 2, pp. 717-21, 2016.
H. - L. Chen, Li, C., Wang, J., Fei, Y., Min, M., Zhao, Y., Shan, E. - F., Yin, Y. - H., Liu, C. - Y., and Li, X. - W., Non-Pharmacological Interventions for Feeding and Eating Disorders in Persons with Dementia: Systematic Review and Evidence Summary., J Alzheimers Dis, vol. 94, no. 1, pp. 67-88, 2023.
P. Lewczuk, Lelental, N., Lachmann, I., Holzer, M., Flach, K., Brandner, S., Engelborghs, S., Teunissen, C. E., Zetterberg, H., Molinuevo, J. Luis, Mroczko, B., Blennow, K., Popp, J., Parnetti, L., Chiasserini, D., Perret-Liaudet, A., Spitzer, P., Maler, J. Manuel, and Kornhuber, J., Non-Phosphorylated Tau as a Potential Biomarker of Alzheimer's Disease: Analytical and Diagnostic Characterization., J Alzheimers Dis, vol. 55, no. 1, pp. 159-170, 2017.
L. Calderón-Garcidueñas, Mukherjee, P. S., Waniek, K., Holzer, M., Chao, C. - K., Thompson, C., Ruiz-Ramos, R., Calderón-Garcidueñas, A., Franco-Lira, M., Reynoso-Robles, R., González-Maciel, A., and Lachmann, I., Non-Phosphorylated Tau in Cerebrospinal Fluid is a Marker of Alzheimer's Disease Continuum in Young Urbanites Exposed to Air Pollution., J Alzheimers Dis, vol. 66, no. 4, pp. 1437-1451, 2018.
S. Ramanan, Flanagan, E., Leyton, C. E., Villemagne, V. L., Rowe, C. C., Hodges, J. R., and Hornberger, M., Non-Verbal Episodic Memory Deficits in Primary Progressive Aphasias are Highly Predictive of Underlying Amyloid Pathology., J Alzheimers Dis, vol. 51, no. 2, pp. 367-76, 2016.
M. Marano, Pompucci, A., Motolese, F., Rossi, M., Coletta, E., Di Lazzaro, V., Fasano, A., and Petrella, G., Normal Pressure Hydrocephalus in Down Syndrome: The Report of Two Cases., J Alzheimers Dis, vol. 77, no. 3, pp. 979-984, 2020.
O. C. Küster, Laptinskaya, D., Fissler, P., Schnack, C., Zügel, M., Nold, V., Thurm, F., Pleiner, S., Karabatsiakis, A., von Einem, B., Weydt, P., Liesener, A., Borta, A., Woll, A., Hengerer, B., Kolassa, I. - T., and von Arnim, C. A. F., Novel Blood-Based Biomarkers of Cognition, Stress, and Physical or Cognitive Training in Older Adults at Risk of Dementia: Preliminary Evidence for a Role of BDNF, Irisin, and the Kynurenine Pathway., J Alzheimers Dis, vol. 59, no. 3, pp. 1097-1111, 2017.
I. Piaceri, Imperiale, D., Ghidoni, E., Atzori, C., Bagnoli, S., Ferrari, C., Ungari, S., Ambrogio, L., Sorbi, S., and Nacmias, B., Novel GRN Mutations in Alzheimer's Disease and Frontotemporal Lobar Degeneration., J Alzheimers Dis, vol. 62, no. 4, pp. 1683-1689, 2018.
M. Fà, Zhang, H., Staniszewski, A., Saeed, F., Shen, L. W., Schiefer, I. T., Siklos, M. I., Tapadar, S., Litosh, V. A., Libien, J., Petukhov, P. A., Teich, A. F., Thatcher, G. R. J., and Arancio, O., Novel Selective Calpain 1 Inhibitors as Potential Therapeutics in Alzheimer's Disease., J Alzheimers Dis, vol. 49, no. 3, pp. 707-21, 2016.
M. A. Lovell, Lynn, B. C., Fister, S., Bradley-Whitman, M., M Murphy, P., Beckett, T. L., and Norris, C. M., A Novel Small Molecule Modulator of Amyloid Pathology., J Alzheimers Dis, vol. 53, no. 1, pp. 273-87, 2016.
E. N. Wilson, Carmo, S. Do, Welikovitch, L. A., Hall, H., Aguilar, L. Flores, Foret, M. K., M Iulita, F., Jia, D. Tong, Marks, A. R., Allard, S., Emmerson, J. T., Ducatenzeiler, A., and A Cuello, C., NP03, a Microdose Lithium Formulation, Blunts Early Amyloid Post-Plaque Neuropathology in McGill-R-Thy1-APP Alzheimer-Like Transgenic Rats., J Alzheimers Dis, vol. 73, no. 2, pp. 723-739, 2019.

Pages